BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 22584572)

  • 1. Protein inhibitor of activated STAT3 (PIAS3) protein promotes SUMOylation and nuclear sequestration of the intracellular domain of ErbB4 protein.
    Sundvall M; Korhonen A; Vaparanta K; Anckar J; Halkilahti K; Salah Z; Aqeilan RI; Palvimo JJ; Sistonen L; Elenius K
    J Biol Chem; 2012 Jun; 287(27):23216-26. PubMed ID: 22584572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SUMOylation regulates nuclear accumulation and signaling activity of the soluble intracellular domain of the ErbB4 receptor tyrosine kinase.
    Knittle AM; Helkkula M; Johnson MS; Sundvall M; Elenius K
    J Biol Chem; 2017 Dec; 292(48):19890-19904. PubMed ID: 28974580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenovirus E4-ORF3 Targets PIAS3 and Together with E1B-55K Remodels SUMO Interactions in the Nucleus and at Virus Genome Replication Domains.
    Higginbotham JM; O'Shea CC
    J Virol; 2015 Oct; 89(20):10260-72. PubMed ID: 26223632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In situ SUMOylation analysis reveals a modulatory role of RanBP2 in the nuclear rim and PML bodies.
    Saitoh N; Uchimura Y; Tachibana T; Sugahara S; Saitoh H; Nakao M
    Exp Cell Res; 2006 May; 312(8):1418-30. PubMed ID: 16688858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PIAS3 interacts with ATF1 and regulates the human ferritin H gene through an antioxidant-responsive element.
    Iwasaki K; Hailemariam K; Tsuji Y
    J Biol Chem; 2007 Aug; 282(31):22335-43. PubMed ID: 17565989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sumoylation of the estrogen receptor alpha hinge region regulates its transcriptional activity.
    Sentis S; Le Romancer M; Bianchin C; Rostan MC; Corbo L
    Mol Endocrinol; 2005 Nov; 19(11):2671-84. PubMed ID: 15961505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional activity of erythroid Kruppel-like factor (EKLF/KLF1) modulated by PIAS3 (protein inhibitor of activated STAT3).
    Siatecka M; Soni S; Planutis A; Bieker JJ
    J Biol Chem; 2015 Apr; 290(15):9929-40. PubMed ID: 25713074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The SUMO (Small Ubiquitin-like Modifier) Ligase PIAS3 Primes ATR for Checkpoint Activation.
    Wu CS; Zou L
    J Biol Chem; 2016 Jan; 291(1):279-90. PubMed ID: 26565033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association and nuclear translocation of the PIAS3-STAT3 complex is ligand and time dependent.
    Dabir S; Kluge A; Dowlati A
    Mol Cancer Res; 2009 Nov; 7(11):1854-60. PubMed ID: 19903771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of nuclear localization and SUMOylation of the ATBF1 transcription factor in epithelial cells.
    Sun X; Li J; Dong FN; Dong JT
    PLoS One; 2014; 9(3):e92746. PubMed ID: 24651376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Role for Protein Inhibitor of Activated STAT 4 (PIAS4) in the Restriction of Herpes Simplex Virus 1 by the Cellular Intrinsic Antiviral Immune Response.
    Conn KL; Wasson P; McFarlane S; Tong L; Brown JR; Grant KG; Domingues P; Boutell C
    J Virol; 2016 May; 90(9):4807-4826. PubMed ID: 26937035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PIAS3 induction of PRB sumoylation represses PRB transactivation by destabilizing its retention in the nucleus.
    Man JH; Li HY; Zhang PJ; Zhou T; He K; Pan X; Liang B; Li AL; Zhao J; Gong WL; Jin BF; Xia Q; Yu M; Shen BF; Zhang XM
    Nucleic Acids Res; 2006; 34(19):5552-66. PubMed ID: 17020914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of cardiac specific nkx2.5 gene activity by small ubiquitin-like modifier.
    Wang J; Zhang H; Iyer D; Feng XH; Schwartz RJ
    J Biol Chem; 2008 Aug; 283(34):23235-43. PubMed ID: 18579533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PIAS3 enhances the transcriptional activity of HIF-1α by increasing its protein stability.
    Nakagawa K; Kohara T; Uehata Y; Miyakawa Y; Sato-Ueshima M; Okubo N; Asaka M; Takeda H; Kobayashi M
    Biochem Biophys Res Commun; 2016 Jan; 469(3):470-6. PubMed ID: 26697750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ubiquitin-SUMO circuitry controls activated fanconi anemia ID complex dosage in response to DNA damage.
    Gibbs-Seymour I; Oka Y; Rajendra E; Weinert BT; Passmore LA; Patel KJ; Olsen JV; Choudhary C; Bekker-Jensen S; Mailand N
    Mol Cell; 2015 Jan; 57(1):150-64. PubMed ID: 25557546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The intracellular delivery of a recombinant peptide derived from the acidic domain of PIAS3 inhibits STAT3 transactivation and induces tumor cell death.
    Borghouts C; Tittmann H; Delis N; Kirchenbauer M; Brill B; Groner B
    Mol Cancer Res; 2010 Apr; 8(4):539-53. PubMed ID: 20371673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The SUMO E3-ligase PIAS1 regulates the tumor suppressor PML and its oncogenic counterpart PML-RARA.
    Rabellino A; Carter B; Konstantinidou G; Wu SY; Rimessi A; Byers LA; Heymach JV; Girard L; Chiang CM; Teruya-Feldstein J; Scaglioni PP
    Cancer Res; 2012 May; 72(9):2275-84. PubMed ID: 22406621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ZNF451 is a novel PML body- and SUMO-associated transcriptional coregulator.
    Karvonen U; Jääskeläinen T; Rytinki M; Kaikkonen S; Palvimo JJ
    J Mol Biol; 2008 Oct; 382(3):585-600. PubMed ID: 18656483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The SUMO-E3 ligase PIAS3 targets pyruvate kinase M2.
    Spoden GA; Morandell D; Ehehalt D; Fiedler M; Jansen-Dürr P; Hermann M; Zwerschke W
    J Cell Biochem; 2009 May; 107(2):293-302. PubMed ID: 19308990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitric oxide destabilizes Pias3 and regulates sumoylation.
    Qu J; Liu GH; Wu K; Han P; Wang P; Li J; Zhang X; Chen C
    PLoS One; 2007 Oct; 2(10):e1085. PubMed ID: 17987106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.